Gene · 337
Papers3,283
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,283
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Plasma proteomic profiling identifies apolipoprotein A4 as a downregulated biomarker of adrenocortical carcinoma: a multi-platform discovery and validation study. | Eur J Endocrinol | 2026 | 42097574 | PubTator, text mining | PubMed |
| Proteomics in Cardiovascular Deaths, a Postmortem Pilot Study: The Diagnostic Efficacy of α-1 Antitrypsin and Apolipoprotein A-IV in Ischemic and Congestive Deaths. | Diagnostics (Basel) | 2026 | 42072817 | PubTator, text mining | PubMed |
| Persistent fatigue in long-COVID is not associated with peripheral inflammatory or cellular stress biomarkers: A cross-sectional controlled study. | Brain Behav Immun Health | 2026 | 42004496 | PubTator, text mining | PubMed |
| Unsupervised clustering of clinical and laboratory features of systemic lupus erythematosus: insights from a multicentre cohort. | Lupus Sci Med | 2026 | 41951250 | PubTator, text mining | PubMed |
| Advanced microfluidic and 3D cell culture platforms for modeling vascularization in diabetic foot ulcers: A systematic review of translational challenges and perspectives. | PLoS One | 2026 | 41941538 | PubTator, text mining | PubMed |
| Deciphering Apolipoprotein A4 in the Protein Corona of Ligand-Modified Liposomes for Tumor Targeting and Penetration. | ACS Nano | 2026 | 41941209 | PubTator, text mining | PubMed |
| Analysis of Purity and Quality of Small Extracellular Vesicles Isolated from Blood Plasma by Proteomics and Raman Spectroscopy. | Biochemistry (Mosc) | 2026 | 41936559 | PubTator, text mining | PubMed |
| Hepatitis E virus replication is maintained in proliferative cells within the intestinal crypt. | Sci Adv | 2026 | 41920986 | PubTator, text mining | PubMed |
| Fibrillary Glomerulonephritis and Apolipoprotein A-IV Amyloidosis: A Rare Dual Pathology Diagnosed by Mass Spectrometry and DNAJB9 Immunohistochemistry. | Kidney Med | 2026 | 41884769 | PubTator, text mining | PubMed |
| Biomarker tests of progression from tuberculosis infection to disease: a systematic review. | Eur Respir Rev | 2026 | 41881453 | PubTator, text mining | PubMed |
| Apolipoprotein A-IV Cardiac Amyloidosis Diagnosed by Mass Spectrometry-Based Proteomic Analysis. | JACC Case Rep | 2026 | 41824610 | PubTator, text mining | PubMed |
| On a quest for fingerprints of crystalglobulinemia on platelets and endothelium. | Blood Vessel Thromb Hemost | 2026 | 41810156 | PubTator, text mining | PubMed |
| Small extracellular vesicles in clinical Cancer research - A quantitative proteomics perspective. | J Proteomics | 2026 | 41806951 | PubTator, text mining | PubMed |
| Plasma Proteomic Dynamics Preceding Glaucoma Reveal a 15-Year Pre-Diagnostic Window: Causal Insights and Predictive Utility in 45,850 Participants. | Invest Ophthalmol Vis Sci | 2026 | 41789843 | PubTator, text mining | PubMed |
| Distinct Proteomic Signatures Driving Progression of Sarcopenia: A Longitudinal Multicohort Study. | J Cachexia Sarcopenia Muscle | 2026 | 41782349 | PubTator, text mining | PubMed |
| APOs as promising prognostic biomarkers: correlation with tumor-infiltrating leukocytes in endometrial cancer. | Front Immunol | 2026 | 41777895 | PubTator, text mining | PubMed |
| Evaluation of Urine Exosome Lecithin Cholesterol Acyltransferase as a Biomarker for Diabetes Diagnosis and Dyslipidemia. | Diabetes Metab Res Rev | 2026 | 41774528 | PubTator, text mining | PubMed |
| Adaptations to endurance vs strength training in elite athletes revealed by serum proteomics. | J Sci Med Sport | 2026 | 41760417 | PubTator, text mining | PubMed |
| Nanoparticles in Thyroid Autoimmunity: Diagnostic and Therapeutic Applications. | J Clin Med | 2026 | 41753116 | PubTator, text mining | PubMed |
| 3D Visualization and Proteomic Analysis of Human Cardiac Transthyretin Amyloidosis Tissue Reveals Microangiopathy and Capillary Occlusion. | bioRxiv | 2026 | 41726908 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/337/papers?page=2